Back | Next |
home / stock / crdf / crdf message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: CRDF 33% v19,1M c11.60 f23,2M H11.87nice weekly chart 5x run from June | znewcar1 | investorshangout | 09/21/2020 9:27:29 PM |
* * $CRDF Video Chart 09-21-2020 * * | ClayTrader | investorshub | 09/21/2020 8:57:16 PM |
znewcar1: CRDF 39% v47,3N c8.11 f23,2M H11.18 S8 | znewcar1 | investorshangout | 09/17/2020 9:34:41 PM |
* * $CRDF Video Chart 09-17-2020 * * | ClayTrader | investorshub | 09/17/2020 9:22:54 PM |
Cardiff Oncology Presents Data at ESMO Confirming Efficacy | MegaDeath | investorshub | 09/17/2020 12:40:13 PM |
Cardiff Oncology to Participate in Fireside Chat at | MegaDeath | investorshub | 08/04/2020 3:42:07 PM |
Cardiff Oncology Secures $13.5 Million Equity Investment from | MegaDeath | investorshub | 06/16/2020 12:51:05 PM |
Cardiff Oncology Data Continues to Demonstrate Efficacy, Durability | MegaDeath | investorshub | 06/15/2020 6:15:18 PM |
CRDF news | MegaDeath | investorshub | 06/09/2020 12:22:56 PM |
znewcar1: CRDF 21% v940K c2.99 f13,5M H3 | znewcar1 | investorshangout | 06/02/2020 12:08:35 AM |
CRDF news | MegaDeath | investorshub | 05/29/2020 12:45:08 PM |
CRDF news | MegaDeath | investorshub | 05/28/2020 1:12:50 PM |
CRDF news | MegaDeath | investorshub | 05/27/2020 12:30:06 PM |
Major insider buying. What's the news? | briphelps | investorshub | 05/20/2020 9:21:06 PM |
Running up nicely! | scotsand | investorshub | 05/19/2020 6:31:01 PM |
CRDF news | MegaDeath | investorshub | 05/19/2020 1:01:53 PM |
znewcar1: CRDF 32% v2,2M c1.90 f13,3M H1.99 S1.77 | znewcar1 | investorshangout | 05/17/2020 4:51:47 PM |
Need to have a Mod request change to | MegaDeath | investorshub | 05/13/2020 4:05:43 PM |
Are we going to have a CRDF board? | abracky | investorshub | 05/13/2020 3:59:34 PM |
CRDF news | MegaDeath | investorshub | 05/13/2020 1:18:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Cardiff Oncology Inc. Company Name:
CRDF Stock Symbol:
NASDAQ Market:
Cardiff Oncology Inc. Website:
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present at two upcoming investor conferences in M...
- In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support ongoing first-line RAS-mutated mCRC lead program - - In RAS wild-type mCRC, preclinical data presented at AACR dem...